According to MMAJunkie, Polish UFC fighter Piotr Hallmann has received a nine month suspension following a failed drug test taken at Fight Night 51. The Brazilian Athletic Commission announced today that Hallman tested positive for the anabolic steroid Drostanolone, which is known for being a very effective cutting agent.
Piotr Hallman (15-3) faced Gleison Tibau (30-10) in UFC Fight Night 51 in Brasilia, Brazil, taking a split decision loss to Tibau. While he lost the lightweight bout, he is expected to lose his part of the $50,000 “fight of the night” bonus awarded after the fight. In addition, he has received a 9 month suspension and must undergo a new drug test before he is able to compete again. Follwing Wanderlei Silva and Cung Le, the problem of PED’s in MMA has come up once again just in recent months. Luckily there is no victory to be taken away on his part, but the problem of performance enhancing drugs and equal punishment for their use continues on to be a major problem in MMA.
The Brazilian Athletic Commission (CABMMA) released this statement on Fight Night 51 Athletes today:
All athletes from the card were tested for anti-doping control upon arrival at Nilson Nelson Arena to detect anabolic agents, diuretic/other masking agents, stimulants and cannabinoids. Four athletes were randomly selected to also be tested for erythropoietin (EPO) and levels of human growth hormone (Hgh).
The athlete Piotr Hallman failed the test due to presence of anabolic steroid drostanolone. He will be suspended for nine months, reatroactibve to the date of his fight. To be licensed again by CABMMA, he will need to go through new anti-doping control tests.
Following the Tibau loss, Hallmann is now 2-2 in the UFC, taking wins over over Yves Edwards and Francisco Trinaldo.